Webcasts & Presentations

Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.

December 5, 2023

Neurocrine Biosciences’ Analyst Day and Webcast on Tuesday, December 5, 2023

Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, will hold its Analyst Day focused on its R&D portfolio and strategy on Tuesday, December 5, 2023 in New York. The event will be held in-person and via webcast. It will feature Kevin Gorman, Chief Executive Officer, and Jude Onyia, Chief Scientific Officer, as well as additional members of Neurocrine Biosciences’ management team who will facilitate a panel discussion on the burden of congenital adrenal hyperplasia.

The event schedule and Zoom webcast information is as follows:

  • Analyst Day Event:    1:00 p.m. – 3:45 p.m. Eastern Time
  • Zoom Webinar ID:     831 1056 0450
  • Zoom Passcode:        536894

Placeholder Link to Corporate Presentation [to be Updated Following Event Conclusion]

OPEN WEBCAST
November 14, 2023

Neurocrine Biosciences to Present at the Jefferies London Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Jefferies London Healthcare Conference on Tuesday November 14, 2023 at 3:00 p.m. Greenwich Mean Time (10:00 a.m. Eastern Time) in London. Kevin Gorman, Chief Executive Officer, and additional members of Neurocrine management will present at the conference.

OPEN WEBCAST
Resources

Email Alerts

To stay up to date on Neurocrine Biosciences, please sign up for our email alerts.

Sign Up Now